Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 319

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 319
---
 the Company if the SPAC Shareholders’ Approval shall not have been obtained by reason of the failure to obtain the required vote at the SPAC Shareholders’ Meeting duly convened therefor or at any adjournment thereof; 153 •by written notice to the Company from SPAC if there is any breach of any covenant or agreement on the part of the Company or Merger Sub set forth in the Business Combination Agreement, or if any representation or warranty of the Company, or Merger Sub shall have become untrue or inaccurate as of any subsequent date after the date of the Business Combination Agreement, in any case such that any of the conditions specified in the Business Combination Agreement would not be satisfied at Closing, subject to certain exceptions and cure periods set forth in the Business Combination Agreement; •by written notice from either the Company or SPAC to the other if the Closing has not occurred on or before December9, 2024 (the “Outside Date”); provided, however, that the Business Combination Agreement may not be terminated under this section by or on behalf of any party that either directly or indirectly through its affiliates materially breaches or violates any representation, warranty, covenant, agreement or obligation contained herein and such material breach or violation is the principal cause of the failure to satisfy a condition set forth in the Business Combination Agreement on or prior to December9, 2024 (as the Outside Date has passed, either the Company or OmnigenicsAI may terminate the Business Combination Agreement subject to the foregoing; however, no party to the Business Combination Agreement has elected or expressed an intent to do so); by written notice to SPAC from the Company if there is any breach of any •by written notice to SPAC from the Company if there is any breach of any covenant or agreement on the part of SPAC set forth in the Business Combination Agreement, or if any representation or warranty of SPAC shall have become untrue or inaccurate as of any subsequent date after the date of the Business Combination Agreement, subject to certain exceptions and cure periods set forth in the Business Combination Agreement; or •by written notice to the Company from SPAC if any of the SEC Required Financials shall not have been delivered by the Company to SPAC on or prior to the applicable deadline specified for such SEC Required Financials in the Business Combination Agreement. In the event of termination of the Business Combination Agreement, the Business Combination Agreement shall forthwith become void and have no effect, without any liability on the part of any party thereto or its respective affiliates, officers, directors or shareholders, other than